-
Sunday, November 4, 2012 - 3:15pm
Express Scripts Earnings Preview: More Strong Revenue Expected on Acquisition
Express Scripts (NASDAQ: ESRX), which resumed its relationship with Walgreen (NYSE: WAG) in September, is scheduled to report its third-quarter 2012 results Monday, November fifth, after the closing bell. Among other things, investors will be looking to see how the company's acquisition of Medco...
Read More >> -
UPDATE: ISI Group Initiates SXC Health Solutions with Overweight, $114 PT on Leading Technology Platform
Thursday, July 12, 2012 - 12:13pmISI Group initiated its coverage on SXC Health Solutions (NASDAQ: CTRX) with a rating of Overweight and a price target of $114. ISI Group said, "We are initiating coverage on shares of Catamaran (SXC Health Solutions) with an Overweight rating and a price target of $114.00, which on a forward...
Read More >>
Catamaran
Benzinga Professional
- 6:18 PM America's Car-Mart, Inc. Reports Q4 EPS of $0.92 vs $0.93 Est; Revenue of $125.50M vs $119.20M Est
- 6:17 PM P&G Says Bob McDonald to Retire June 30th, Lafley Joins as Chairman, CEO, President; Reaffirms Q4, FY Outlook
- 6:11 PM DISH Says Its Offer for Sprint is Superior Than Softbank Bid
- 5:52 PM From Pandora Call: Potential Apple iRadio Could Change Royalty Rates
- 05:50 PM Benzinga's M&A Chatter for Thursday May 23, 2013
- 5:35 PM Whitewave Spin-Off from Dean Foods Closes, WhiteWave Announces $150M Buyback Plan
- 5:31 PM Moody's Upgrades Tanger to Baa1
- 5:24 PM Judge in Apple Case Says US Can Show Evidence Apple Was Part of Conspiracy Related to E-Book Prices
- 5:22 PM NBC News Reporting IRS' Lois Lerner Placed on Admin. Leave Today
- 5:05 PM Google Loses Bid to Block US Imports of Microsoft's Xbox, US Trade Agency Says Microsoft Didn't Infringe Google Patent
- 5:04 PM Post Properties Raises Qtr. Dividend from $0.25 to $0.33/Share
- 05:00 PM Merck Issues Update on Phase III Trial for Preladenant
- 5:00 PM Colonial Properties Trust Sells Three Ravinia for $144M
- 4:56 PM Ziopharm IR Spokesperson Says No Company News Related to Unusual Option Activity; Will be Presenting May 29 at Deutsche Bank Health Care Conference
- 04:51 PM Sabra Health Issues Update on Capital Markets Strategy, Says FY13 Adj. FFO Will Be Cut by $0.01/Share
Brain Trust
MORE FROM Michael Prus
MORE FROM InvestorsObserver
- Benzinga's M&A Chatter for Thursday May 23, 2013
- Merck Issues Update on Phase III Trial for Preladenant
- Sabra Health Issues Update on Capital Markets Strategy, Says FY13 Adj. FFO Will Be Cut by $0.01/Share
- Analyzing the Flash Crash in Utilities This Morning
- Wireless Ronin Common Stock to Move to OTCQB; NASDAQ Delisting Based on Insufficient Shareholders' Equity
- Market Wrap for Thursday, May 23: Wall Street Shrugs Off Global Slump
- Nigeria ETF Gets Good News on Glum Day For Global Markets
- Prime Acquisition Announces Receipt of Nasdaq Staff Determination Letter
- Cadence Completes Acquisition of Cosmic Circuits
- Medifast Announces Appointment of New Independent Director
- Will Microsoft's Xbox One Help or Hurt Comcast, Other Cable Giants?
- UPDATE: Goldman Sachs Downgrades Realty Income Corp. to Sell, Raises PT on Valuation, Earnings Growth Profile
- Benzinga's M&A Chatter for Wednesday May 22, 2013
- An ETF For Elon Musk Fans
- These Ridiculous Facts About the Coffee Industry Will Blow Your Mind
- Benzinga Market Primer: Thursday May 23
- UPDATE: Oppenheimer Downgrades iGATE Corporation to Perform, Removes PT Following CEO Termination
- Benzinga Market Primer: Wednesday, May 22
- Apple Tops New WisdomTree Dividend ETF
- Amarin Receive Patent Allowance for Combination Product of Vascepa and Statin Therapy